Group ACYW135 Meningococcal Polysaccharide Vaccine (Beijing Kexing Zhongwei Biotech)

ACYW135็พค่„‘่†œ็‚Ž็ƒ่Œๅคš็ณ–็–ซ่‹—๏ผˆๅŒ—ไบฌ็ง‘ๅ…ดไธญ็ปด็”Ÿ็‰ฉ๏ผ‰

Report date: 2026/04/06 20:01:48

Base Information

Drug NameGroup ACYW135 Meningococcal Polysaccharide Vaccine (Beijing Kexing Zhongwei Biotech)
Drug Alias NameTetravalent meningococcal polysaccharide vaccine (Beijing Kexing Zhongwei Biotech)ACYW135X็พค่„‘่†œ็‚Ž็ƒ่Œๅคš็ณ–็ป“ๅˆ็–ซ่‹—
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[4]ย 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitisEncephalomyelitisMeningococcal Infections +[5]ย 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSinovac Life Sciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac Biotech Co LtdSinovac Life Sciences Co Ltd
Inactive CompaniesN/A
Active IndicationsMeningitisEncephalomyelitisMeningococcal Infections +[5]ย 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A